Skip to content

Patients › Shoulder

Manejo Artroscópico Integral (CAM)

The Comprehensive Arthroscopic Management (CAM) procedure — a joint-preserving arthroscopic alternative to arthroplasty for glenohumeral osteoarthritis, combining debridement, capsular release, osteophyte excision, microfracture, loose-body removal and axillary nerve neurolysis.

Updated Sep 2026
Una ilustración dibujada a mano de un nadador en pleno movimiento de estilo libre.
El tratamiento artroscópico integral permite conservar la articulación nativa; se trata de una opción que preserva la articulación para pacientes jóvenes y activos con artritis avanzada del hombro. Kieran Hirpara 4.0

Esta página se tradujo automáticamente y todavía no la ha revisado un médico. La versión en inglés es la versión oficial.

¿Por qué se ha recomendado esta operación?

El Dr. Kieran Hirpara, cirujano de extremidad superior en el Mater Private Hospital Rockhampton, comienza por proponer las opciones menos invasivas que se adapten a su condición. Por lo general, los pacientes son derivados a nuestra clínica por su médico de cabecera; si un fisioterapeuta le ha sugerido que nos consulte, igualmente necesitará una derivación de su médico de cabecera para poder acceder al reembolso de Medicare. Evaluamos a cada paciente mediante su historia clínica, un examen físico y, cuando es necesario, estudios por imagen.

En el caso de la artritis degenerativa del hombro, normalmente probamos primero tratamientos no quirúrgicos: modificación de las actividades, fisioterapia, medicamentos antiinflamatorios e inyecciones. La cirugía se considera únicamente cuando estos tratamientos no logran una mejora suficiente.

El Manejo Artroscópico Integral (CAM, por sus siglas en inglés) es una intervención mínimamente invasiva que trata las superficies dañadas y los tejidos blandos dentro de la articulación del hombro. Generalmente se recomienda a personas jóvenes y activas que padecen artritis avanzada pero desean conservar su propia articulación y retrasar así una prótesis de hombro. También pueden ser candidatos algunos pacientes con artritis leve pero con dolor significativo.

El objetivo de la operación es reducir el dolor y mejorar el movimiento y la funcionalidad del hombro. En estudios realizados, el 76,9 % de los pacientes sometidos a esta intervención conservaron su propia articulación al menos 5 años después de la cirugía. Analizaremos juntos si este procedimiento es adecuado para usted, y usted participará en la toma de esa decisión.

Antes de la operación

Antes del día de la cirugía, su cirujano le dará instrucciones claras que deberá seguir. Deberá dejar de comer y beber siete horas antes. Esto permite adelantar la operación si la lista de quirófanos se agiliza. Es posible que deba suspender algunos medicamentos; su cirujano le indicará cuáles y por cuánto tiempo. Lleve una lista por escrito de todos los fármacos que toma, incluyendo pastillas, inyecciones y remedios naturales. Organice que alguien lo lleve a casa después de la intervención, ya que no podrá conducir usted mismo. Use ropa holgada y cómoda que sea fácil de poner por encima del hombro. Es posible que se necesiten estudios de imagen como radiografías, resonancia magnética o ecografía para planificar la operación. Si padece otras enfermedades, podría requerir análisis de sangre o una evaluación con el anestesista.

El día de la intervención

Llegará a la unidad de admisiones quirúrgicas del hospital, donde se le registrará y preparará para la cirugía. No irá primero a una sala de hospitalización. El anestesista se reunirá con usted antes de la operación y le explicará ambas fases del procedimiento. Esta intervención se realiza bajo anestesia general combinada con un bloqueo nervioso regional. Usted permanecerá completamente dormido durante la operación; el bloqueo nervioso (una inyección que adormece los nervios que inervan el brazo antes de que usted despierte) le proporcionará alivio del dolor durante las primeras 12 a 24 horas posteriores a la cirugía. A continuación, será llevado al quirófano, donde se realiza la operación.

Despertará en la sala de recuperación, donde las enfermeras lo vigilarán mientras la anestesia va desapareciendo. Una vez que su estado sea estable, será trasladado a la sala de hospitalización o se le permitirá volver a casa, según el tipo de intervención y su recuperación. Dado que el bloqueo nervioso puede adormecer parte de su brazo durante las primeras 12 a 24 horas, necesitará que alguien lo lleve a casa, tal como se indicó en la sección anterior.

¿En qué consiste la operación?

La CAM es una cirugía mínimamente invasiva. El cirujano realiza varias incisiones pequeñas, de aproximadamente 1 cm cada una, alrededor del hombro. A través de estas incisiones se introduce una cámara delgada y pequeños instrumentos para trabajar en el interior de la articulación.

Una vez dentro, el cirujano limpia la articulación. Esto puede implicar la eliminación de fragmentos sueltos de cartílago u hueso, el alisado de las superficies articulares desgastadas y la remoción del tejido inflamado. Se libera el tejido tenso que rodea la articulación para permitir un movimiento más libre del hombro. Si un nervio situado en la parte frontal del hombro está siendo comprimido por tejido cicatricial, se libera. Si el tendón situado en la parte superior del músculo bíceps está desgastado, se fija al hueso del brazo superior para que deje de causar dolor. Se realizan pequeños orificios en el hueso donde el cartílago está desgastado; esto favorece el crecimiento de nuevo tejido cicatricial que amortigua la articulación. Asimismo, se recortan los espolones óseos que se encuentran en la parte inferior de la cabeza articular.

Las pequeñas incisiones se cierran con puntos de sutura y se cubren con un vendaje. Al irse a casa, recibirá instrucciones sobre el cuidado del hombro; el vendaje se mantiene durante unos 10 días.

Después de la operación

La mayoría de los pacientes permanecen una noche en el hospital tras esta operación, aunque algunos pueden volver a casa el mismo día. Despertará en la sala de recuperación y luego será trasladado a la planta de hospitalización. Durante las primeras 12 a 24 horas, su brazo podría sentirse entumecido o pesado debido al bloqueo nervioso. A medida que este efecto disminuya, es posible que sienta cierta molestia; las enfermeras le administrarán analgésicos para mantenerla bajo control. Regresará a casa con el brazo sostenido mediante un cabestrillo. Dejamos el vendaje puesto durante unos 10 días; por favor, no lo retire antes de ese momento a menos que se lo indiquemos. Lo cambiaremos o lo quitaremos cuando venga a la consulta. La mayoría de las personas pueden caminar y realizar tareas ligeras en casa de inmediato. Por favor, asegúrese de que alguien se quede con usted durante las primeras 24 horas.

Recuperación

Durante el primer día o dos, su brazo se sentirá entumecido y pesado debido al bloqueo nervioso. A medida que este efecto disminuya, es normal experimentar cierta molestia e hinchazón alrededor del hombro. El descanso, las compresas frías y el plan de alivio del dolor que le proporcionamos le ayudarán a controlar estos síntomas. La mayoría de las personas notan que la molestia disminuye progresivamente durante las primeras dos semanas.

Al regresar a casa, llevará el brazo en un cabestrillo. Su fisioterapeuta le guiará en la realización de movimientos suaves al principio, para luego aumentar gradualmente la intensidad de los ejercicios según lo permita su hombro. Podrá caminar y realizar tareas ligeras en casa de inmediato; sin embargo, al principio necesitará ayuda para vestirse o alcanzar objetos por encima de la cabeza. En los primeros días, suele ser más cómodo dormir en posición vertical o apoyado en almohadas. Mantenga el vendaje seco y no lo toque; lo revisaremos con usted en su próxima consulta.

La recuperación se produce por etapas, y cada una depende de la capacidad funcional de su hombro en lugar de de una fecha determinada. A medida que disminuye la hinchazón y recupera el movimiento, las actividades diarias se vuelven más fáciles. Una vez que su cirujano lo autorice, generalmente en la revisión a las seis semanas, podrá volver a conducir; consulte nuestra guía sobre Conducción tras una cirugía de extremidad superior. El fortalecimiento muscular es el último paso, cuando su hombro lo tolera sin provocar dolor.

Cada persona sana a su propio ritmo, por lo que su cronograma puede variar. Su cirujano y fisioterapeuta evaluarán su progreso en cada visita y ajustarán el plan si fuera necesario.

Qué puede salir mal

La mayoría de los pacientes evolucionan bien, pero en ocasiones pueden presentarse problemas. Su cirujano y el equipo lo supervisarán de cerca para detectar cualquier incidencia a tiempo.

En general, la cirugía artroscópica de hombro presenta una tasa baja de complicaciones. Aun así, es útil saber qué síntomas debe vigilar durante las primeras semanas.

Si ya padece síndrome del túnel carpiano o inflamación tendinosa en los dedos o la mano, infórmenos antes de la operación. Estas condiciones aumentan la probabilidad de problemas en la mano y los dedos tras la cirugía. La hinchazón en la mano también puede tener el mismo efecto. Es posible que note hormigueo, entumecimiento o hinchazón en los dedos que antes no existían. Coméntele esto en su próxima revisión, o llame a la clínica si empeora rápidamente.

La rigidez es el problema más frecuente tras la cirugía artroscópica de hombro. Su hombro podría sentirse tenso y difícil de mover; esta rigidez podría no ceder con el reposo. Si los movimientos simples siguen siendo dolorosos y limitados después de las primeras dos semanas, mencione esto en su revisión. En la mayoría de los casos, la rigidez desaparece por sí sola sin necesidad de otra intervención quirúrgica.

Tener artritis en el mismo hombro incrementa el riesgo de complicaciones, tanto inmediatamente después de la cirugía como más adelante. Este es uno de los motivos por los que analizamos detalladamente las opciones con usted antes de decidir llevar a cabo esta operación.

Durante la cirugía artroscópica, pequeñas herramientas introducen los puntos de sutura a través del tejido. En ocasiones, una de estas herramientas puede romperse, dejando un fragmento diminuto dentro de la articulación. Normalmente usted no lo notaría. Su cirujano vigila este detalle durante la operación y lo gestiona en ese momento.

En la tabla de complicaciones de esta página se detallan las tasas habituales, por si desea conocer los datos específicos.

¿Cuándo deben llamarnos?

La mayoría de las personas se recuperan sin problemas; sin embargo, algunos síntomas requieren atención inmediata. Llámenos de inmediato si tiene fiebre, o si la piel alrededor de las heridas se vuelve cada vez más roja o comienza a secretar líquido. Acuda a urgencias si experimenta dolor intenso y repentino, hinchazón en la pantorrilla o dificultad para respirar. Llámenos si su mano o brazo pierde sensibilidad, o si no puede moverlo en absoluto. Si no está seguro de si un síntoma es grave, llame a la clínica y le ayudaremos a decidir.

¿Dónde leer más sobre esta afección?

Esta página trata sobre la operación en sí. La afección que se trata con ella, incluyendo lo que demuestran las evidencias sobre cuándo la cirugía es útil y cuándo no, se explica con mayor detalle en la página Artritis del hombro.


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • The Comprehensive Arthroscopic Management (CAM) procedure is a systematic, inclusive approach to the array of pathologies encountered in the setting of early glenohumeral arthritis [1].
  • The CAM procedure reduced pain, improved function, and provided reasonable short-term durability for young, active patients with advanced shoulder osteoarthritis [2].
  • The CAM procedure serves as a joint-preserving alternative to arthroplasty for young, active patients with advanced shoulder osteoarthritis [2].
  • The comprehensive arthroscopic management procedure provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis [3].
  • The comprehensive arthroscopic management procedure reduces pain and improves function in younger, high-demand patients with advanced glenohumeral osteoarthritis [3].
  • The arthroscopic CAM procedure for glenohumeral osteoarthritis demonstrated significant improvements in midterm clinical outcomes [6].
  • The arthroscopic CAM procedure for glenohumeral osteoarthritis demonstrated high patient satisfaction [6].
  • The arthroscopic CAM procedure for glenohumeral osteoarthritis had a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
  • Arthroscopic debridement improved clinical outcome in 68% of patients suffering from advanced osteoarthritis of the glenohumeral joint [7].
  • Treatment of glenohumeral arthritis with arthroscopic glenoid resurfacing provided superior results to previously performed arthroscopic procedures in patients with failed previous arthroscopic debridement [9].
  • Arthroscopic debridement is an excellent treatment for elderly patients with modest functional demands [10].
  • Long-term consequences of arthroscopic debridement for elderly patients with modest functional demands require further evaluation [10].
  • CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings [12].
  • Hemiarthroplasty or total shoulder arthroplasty are feasible options for patients with humeral head incongruity or large anterior osteophytes [12].
  • Isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients with glenohumeral arthritis [15].
  • Surgical arthroscopic repair was possible in all cases of acute or recurrent instability in soccer goalkeepers with well-defined exclusion criteria [19].

Anatomy & Pathophysiology

Bony Anatomy

  • The proximal humerus comprises the humeral head, greater tuberosity, lesser tuberosity, and humeral shaft [29].
  • The articular head of the humerus is spherical with a diameter of 37 to 57 mm [29].
  • The most superior portion of the articular surface of the humeral head averages 8 mm above the greater tuberosity [29].
  • Humeral version averages 29.8 degrees, with a range of 10 to 55 degrees [29].
  • The humeral head is inclined approximately 130 degrees with respect to the humeral shaft [29].
  • The bicipital groove lies between the greater and lesser tuberosities and serves as a pathway for the long head of the biceps [29].
  • The distal aspect of the bicipital groove is internally rotated with respect to the proximal portion [29].
  • The anatomic neck of the proximal humerus is located at the junction of the articular surface and the tuberosities [29].
  • The surgical neck represents an indistinct region below the tuberosities but above the humeral shaft [29].
  • The greater tuberosity is located in a posterior-superior location with respect to the humeral shaft and serves as the attachment site for the supraspinatus, infraspinatus, and teres minor tendons [29].
  • The lesser tuberosity is located on the anterior aspect of the proximal humerus and serves as the attachment site for the subscapularis tendon [29].
  • The glenoid is a convex structure of shallow depth shaped like an inverted pear [29].
  • The glenoid cavity is a shallow socket, approximately one third the size of the humeral head [30].
  • The neck-shaft angle of the proximal humerus measures an average of 135 degrees [30].
  • The humeral head is retroverted an average of 30 degrees [30].
  • The humeral head averages 19° of retroversion and 41° of inclination [32].
  • The glenoid averages 5° of retroversion in relation to the axis of the scapular body [32].
  • The subchondral bone of the glenoid is relatively flat, with articular concavity augmented by cartilage and a circumferential labrum [32].
  • The scapula is attached to the axial skeleton by the acromioclavicular and sternoclavicular joints [31].
  • The scapular body is triangular when viewed anteroposteriorly, with its base situated superiorly and its apex inferiorly [31].
  • The glenoid is connected with the flat body of the scapula by the scapular neck [31].
  • The coracoid process curves forwards from the superior surface of the scapular neck [31].
  • The scapular spine ends in a flattened bony process, the acromion, which curves forwards [31].
  • The lateral pillar connects the inferior border of the glenoid with the inferior angle of the scapula [31].
  • The spinal pillar arises from the central part of the glenoid and continues medially to become part of the base of the scapular spine [31].
  • The weakest bone in the scapula is located primarily in the central part of the biomechanical body, specifically in the infraspinous fossa [31].
  • The weakest area of the circumference of the biomechanical body of the scapula is the spinomedial angle [31].
  • The acromion has three ossification centers: the metacromion, mesoacromion, and preacromion [32].
  • The proximal humerus has three centers of ossification: the humeral head, greater tuberosity, and lesser tuberosity [32].

Vascular and Neural Anatomy

  • The proximal humerus receives its blood supply from the anterior and posterior humeral circumflex branches from the third division of the axillary artery [29].
  • The posterior humeral circumflex artery travels with the axillary nerve, enters the quadrilateral space posteriorly, and anastomoses with a branch of the anterior circumflex to supply the posterior cuff [29].
  • The anterior humeral circumflex artery arises from the axillary artery at the inferior border of the subscapularis [29].
  • The anterior humeral circumflex artery provides vascular inflow to the humeral head by way of its terminal anterolateral branch, known as the artery of Laing or arcuate artery [29].
  • The ascending branch of the anterior humeral circumflex artery courses parallel to the lateral aspect of the long head biceps tendon and enters the humeral head at the interface of the bicipital groove and greater tuberosity [29].
  • Injury to the arcuate artery may result in osteonecrosis of the humeral head [29].
  • Additional extraosseous collateral branches can permit humeral head perfusion despite complete ligation of the arcuate artery [29].
  • The anterolateral ascending branch of the anterior humeral circumflex artery provides the primary blood supply to the humeral head [32].
  • The terminal intraosseous portion of the anterior humeral circumflex artery enters at the proximal aspect of the intertubercular groove as the arcuate artery [32].
  • The axillary nerve passes from anteromedial to posterolateral toward the quadrilateral space just inferior to the joint [5].
  • An axillary nerve injury from proximal humeral fracture or fracture-dislocation results in paralysis of the deltoid muscle and anesthesia over the “badge” region at the lateral proximal arm [30].
  • The brachial plexus and axillary artery are located anterior to the coracoid process of the scapula and humeral head [30].

Soft Tissue and Joint Structures

  • The rotator cuff consists of the subscapularis, supraspinatus, infraspinatus, and teres minor muscles [30].
  • The teres major is not a rotator cuff muscle [30].
  • The rotator cuff muscles serve as depressors of the humeral head to allow the deltoid to efficiently abduct the humerus [30].
  • The infraspinatus and teres minor are external rotators, while the subscapularis is an internal rotator of the humerus [30].
  • The acromion, coracoacromial ligament, and coracoid process form the coracoacromial arch [29].
  • The rotator cuff, subacromial bursa, and subdeltoid bursa pass underneath the coracoacromial arch [29].
  • The glenohumeral joint is stabilized dynamically by the rotator cuff via joint compression and by the positioning of the scapulothoracic joint [32].
  • Static stabilizers of the glenohumeral joint include articular congruity, the glenoid labrum, concavity-compression, negative intra-articular pressure, and the glenohumeral capsule and ligaments [32].
  • The glenoid labrum provides concavity and up to 50% of marginal glenoid socket depth [32].
  • The rotator interval is defined medially by the base of the coracoid, superiorly by the supraspinatus tendon, and inferiorly by the subscapularis tendon [32].
  • The rotator interval contains the coracohumeral ligament, the superior glenohumeral ligament, and the intra-articular portion of the long head of the biceps tendon [32].
  • Laxity of the rotator interval results in inferior laxity, known as the sulcus sign [32].
  • Contracture of the rotator interval is seen with adhesive capsulitis [32].
  • The coracohumeral ligament restricts external rotation in adduction and is a static restraint to inferior and posterior translation in adduction and external rotation [32].
  • The superior glenohumeral ligament is a primary static restraint against anterior translation with the arm at the side [32].
  • The superior glenohumeral ligament and coracohumeral ligament form a pulley that provides restraint against medial subluxation of the long head of the biceps tendon [32].
  • The middle glenohumeral ligament is a primary static restraint against anterior translation with the arm in external rotation and 45° of abduction [32].
  • The anterior band of the inferior glenohumeral ligament is a primary static restraint against anterior-inferior dislocation of the glenohumeral joint in 90° of abduction and external rotation [32].
  • The posterior band of the inferior glenohumeral ligament is a primary static restraint against posterior-inferior translation in internal rotation and adduction [32].
  • The subscapular bursa lies between the subscapularis tendon and the neck of the scapula [33].
  • The subscapular bursa communicates with the joint cavity between the superior and middle glenohumeral ligaments [33].
  • The subscapular bursa protects the tendon of the subscapularis at the point where it passes under the base of the coracoid process and over the neck of the scapula [33].
  • The subscapular bursa often houses loose bodies in the shoulder [33].
  • Synovitis of the shoulder may be most intense in the subscapular bursa region, where small fringes or villi can project into the joint cavity [33].
  • A soft tissue sheath consistently covers the long head of the biceps tendon to the level of the proximal margin of the pectoralis major tendon [33].
  • The fibro-osseous bicipital tunnel consists of three distinct anatomic zones: Zone 1 (bony groove), Zone 2 ("no man's land"), and Zone 3 (subpectoral region) [33].
  • Zone 1 of the bicipital tunnel represents the traditional bony bicipital groove beginning at the articular margin and ending at the distal margin of the subscapularis tendon [33].
  • Zone 2 of the bicipital tunnel extends from the distal margin of the subscapularis tendon to the proximal margin of the pectoralis major tendon and is not viewable from arthroscopy above or from subpectoral exposure below [33].
  • Zone 3 of the bicipital tunnel is distal to the proximal margin of the pectoralis major tendon and represents the subpectoral region [33].

Pathophysiology

  • Stability and function of the glenohumeral joint are provided by the interaction of structures that promote a near global range of motion and purposeful function [29].
  • External loads transferred to the shoulder girdle are initially offset by joint surface anatomy, joint volume, atmospheric pressure, and joint fluid cohesion and adhesion [29].
  • Moderate and large loads are counterbalanced by the deltoid and rotator cuff and by the capsulolabral and bone structures, respectively [29].
  • Pathologic humeral fractures alter complex interactions in the shoulder girdle, resulting in pain, decreased range of motion and stiffness, and disability [29].
  • Displacement of proximal humeral fracture fragments occurs in a predictable manner based on the deforming forces created by the tendinous insertions of the pectoralis major, subscapularis, supraspinatus, and infraspinatus [29].
  • The subscapularis inserts on the lesser tuberosity and causes medial displacement of fracture fragments [29].
  • The supraspinatus and infraspinatus insert on the greater tuberosity and cause superior and posterior displacement of fracture fragments [29].
  • The pectoralis major inserts on the humeral shaft and displaces it medially [29].
  • Fractures involving the anatomic neck are prognostically worse than fractures involving other regions of the proximal humerus with respect to the potential disruption of the vascular supply to the humeral head and subsequent development of avascular necrosis [29].
  • Normal shoulder motion is approximately two-thirds glenohumeral and one-third scapulothoracic [32].
  • The superior shoulder suspensory complex provides a stable connection between the scapula and the axial skeleton [32].
  • The superior shoulder suspensory complex is composed of the glenoid, coracoid process, coracoclavicular ligaments, distal clavicle, acromioclavicular joint, and acromion [32].
  • The superior strut of the superior shoulder suspensory complex comprises the middle clavicle [32].
  • The inferior strut of the superior shoulder suspensory complex comprises the lateral scapular border and spine of the scapula [32].
  • Arthritis usually involves the central aspect of the humeral head [22].
  • Joint space narrowing is most evident on the axillary "truth view" as opposed to images made with the arm at the side [22].
  • The axillary "truth view" demonstrates posterior subluxation or "functional decentering" that is not evident in images taken with the arm at the side [22].
  • Malcentering of the joint reaction force leads to posterior instability, posterior glenoid wear, and "rocking horse" loosening of prosthetic glenoid components [22].
  • The degree of posterior subluxation can be measured by the position of the center of the humeral head in relation to the plane of the scapula, the position of the center of the humeral head in relation to the glenoid face, or the point of contact of the humeral articular surface on the glenoid articular surface [22].
  • The point of contact of the humeral articular surface on the glenoid articular surface reflects the degree of centering of the net humeral joint reaction force on the glenoid [22].
  • Loss of humeral lateral offset due to medial joint erosion is observed in glenohumeral arthritis [22].
  • A "Friar Tuck" pattern of central baldness is commonly seen in primary degenerative joint disease, with remaining articular cartilage at the periphery [22].

Classification

  • Patients are excluded from CAM if they have early-stage glenohumeral osteoarthritis defined as Kellgren-Lawrence grade 1 or 2 [8].
  • Patients are excluded from CAM if they have not undergone a trial of nonoperative measures [8].
  • Patients are excluded from CAM if they have irreparable rotator cuff tears [8].
  • Patients are excluded from CAM if they have severe bipolar chondral lesions with diffuse flattening of the humeral head [8].
  • Total shoulder arthroplasty is suggested over CAM for patients with a type B2 or C glenoid according to the Walch classification [8].
  • Total shoulder arthroplasty is suggested over CAM for patients with less than 2 mm of glenohumeral joint space [8].

Clinical Presentation

  • The Comprehensive Arthroscopic Management (CAM) procedure is recommended as a systematic, inclusive approach to the array of pathologies encountered in the setting of early glenohumeral arthritis [1].
  • The CAM procedure provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis [3].
  • Arthroscopic management of glenohumeral osteoarthritis is an emerging and evolving procedure to treat the challenging problem of glenohumeral osteoarthritis in young and high-demand patients [4].
  • Patients undergoing the CAM procedure met the clinical and radiographic criteria for total shoulder joint replacement but elected to undergo a joint-preserving technique to avoid or delay total shoulder arthroplasty [8].
  • Exclusion criteria for the CAM procedure include early-stage glenohumeral osteoarthritis (Kellgren-Lawrence grade 1 or 2) [8].
  • Exclusion criteria for the CAM procedure include no trial of nonoperative measures [8].
  • Exclusion criteria for the CAM procedure include irreparable rotator cuff tears [8].
  • Exclusion criteria for the CAM procedure include severe bipolar chondral lesions with diffuse flattening of the humeral head [8].
  • Total shoulder arthroplasty is suggested over the CAM procedure if patients have a type B2 or C glenoid according to the Walch classification [8].
  • Total shoulder arthroplasty is suggested over the CAM procedure if patients have less than 2 mm of glenohumeral joint space [8].
  • Preoperative symptoms consistent with axillary nerve impingement or compression include posterior and lateral shoulder pain [5].
  • Preoperative symptoms consistent with axillary nerve impingement or compression include atrophy of the teres minor or posterior deltoid [5].
  • Preoperative symptoms consistent with axillary nerve impingement or compression include weakness in external rotation without the presence of a rotator cuff tear [5].
  • Axillary nerve decompression is considered if an inferior humeral osteophyte changed the course of the nerve as determined on preoperative MRI [5].
  • Axillary nerve decompression is considered if the nerve is observed intraoperatively by displacement of the inferior capsule [5].

Investigations

Radiographic Evaluation

  • The purpose of imaging the shoulder is to help establish the diagnosis, determine the severity of the pathoanatomy, assist in surgical planning, and enable the surgeon to illustrate the condition of the shoulder to the patient [22].
  • Unless a specific research protocol is in place, the temptation to “overimage” should be resisted, obtaining only the scans or reconstructions that are necessary for the care of the patient [22].
  • Standardized plain films are almost always sufficient to garner the information needed for glenohumeral arthritis evaluation [22].
  • Proper radiographic technique is as important as proper surgical technique to achieve the desired outcome [22].
  • The first key radiographic view is the anteroposterior (AP) in the plane of the scapula taken so that the x-ray beam passes through the glenohumeral joint [22].
  • The AP view in the plane of the scapula shows the superoinferior position of the humeral head relative to the glenoid, the presence of osteophytes on the humeral head and glenoid, narrowing of the joint space, and the degree of medial displacement of the humerus in relation to the lateral acromial line [22].
  • The AP view in the plane of the scapula also shows the quality of the humeral and glenoid bone, the presence of loose bodies, and whether there is humeral head collapse or deformity [22].
  • The second key radiographic view is the axillary view taken with the arm in the functional position of elevation in the plane of the scapula [22].
  • The axillary view is oriented so that both the spinoglenoid notch and the scapular neck are visible [22].
  • The axillary view shows a different perspective of the humeral anatomy, the amount of glenoid bone, the shape of the glenoid, its version in relation to the plane of the scapula, and the relationship of the humeral head to the glenoid fossa [22].
  • The axillary view is referred to as the “truth view” because it demonstrates the glenohumeral relationships in the functional position of elevation [22].
  • CT scans have the disadvantage of being taken with the arm in the adducted position, whereas the axillary truth view is taken with the arm in elevation [22].
  • Many “axillary views” sent for consultation are taken without standardization, making it impossible to determine the important features of the glenohumeral joint [22].
  • When taken properly, standardized anteroposterior and axillary views indicate the thickness of the cartilage space between the humerus and the glenoid, relative positions of the humeral head and the glenoid, presence of osteophytes, degree of osteopenia, and extent of bony deformity and erosion [22].
  • Joint space narrowing is most evident on the axillary truth view as opposed to images made with the arm at the side because arthritis usually involves the central aspect of the humeral head [22].
  • The standardized axillary view enables the detection of posterior subluxation or “functional decentering” that is not evident in images taken with the arm at the side [22].
  • The degree of posterior subluxation can be measured as the position of the center of the humeral head in relation to the plane of the scapula [22].
  • The degree of posterior subluxation can be measured as the position of the center of the humeral head in relation to the glenoid face [22].
  • The degree of posterior subluxation can be measured as the point of contact of the humeral articular surface on the glenoid articular surface [22].
  • At least two X-ray views should be obtained for shoulder imaging: an anteroposterior in the plane of the glenoid and an axillary projection with the arm in abduction to show the relationship of the humeral head to the glenoid [37].
  • CT scans may offer a few degrees of increased precision in the measurement of glenoid version, but this precision does not necessarily improve the quality of the surgery or the clinical outcome [22].

Magnetic Resonance Imaging

  • Magnetic resonance imaging (MRI) is useful to identify osteonecrosis of the humeral head, or a bone tumour [37].
  • MRI can identify labral tears and rotator cuff tears, although the accuracy for these is enhanced by combining the scan with arthrography [37].
  • Preoperative MRI is used to determine if an inferior humeral osteophyte changed the course of the axillary nerve [5].
  • Preoperative symptoms consistent with axillary nerve impingement or compression include posterior and lateral shoulder pain, atrophy of the teres minor or posterior deltoid, and weakness in external rotation without the presence of a rotator cuff tear [5].

Computed Tomography

  • Computed tomography (CT) is helpful for planning fracture surgery and shoulder joint replacement [37].
  • Three-dimensional reconstructions based on CT scans of the arthritic shoulder are currently discussed in comparison to imaging consisting only of two standardized plain films [39].

Ultrasound

  • Ultrasound is a simple and accurate test for identifying rotator cuff tears and calcific tendinitis [37].
  • Ultrasound can be useful in guiding injections or barbotage (aspirating calcific deposits in the rotator cuff) [37].
  • The most commonly performed joint examination using ultrasonography is the shoulder examination [35].
  • Accuracy of rotator cuff ultrasonography depends on the skill of the scanner operator and an awareness of pitfalls that are encountered [35].

Arthroscopy

  • Arthroscopy is useful for diagnosing and treating subacromial impingement, intra-articular lesions, detachment of the glenoid labrum and rotator cuff tears [37].
  • Diagnostic arthroscopy is performed to identify and treat all intra-articular pathologic abnormalities during the CAM procedure [5].
  • Fluoroscopy is used to confirm adequate resection of inferior humeral head osteophytes during the CAM procedure [5].

Treatment

Indications and Patient Selection

  • The Comprehensive Arthroscopic Management (CAM) procedure is recommended as a systematic, inclusive approach for pathologies encountered in early glenohumeral arthritis [1].
  • CAM serves as a joint-preserving alternative to arthroplasty for young, active patients with advanced shoulder osteoarthritis [2].
  • CAM provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis [3].
  • CAM is indicated for patients who meet clinical and radiographic criteria for total shoulder joint replacement but elect to undergo a joint-preserving technique to avoid or delay total shoulder arthroplasty [8].
  • Exclusion criteria for the CAM procedure include early-stage glenohumeral osteoarthritis (Kellgren-Lawrence grade 1 or 2), no trial of nonoperative measures, irreparable rotator cuff tears, and severe bipolar chondral lesions with diffuse flattening of the humeral head [8].
  • Total shoulder arthroplasty is suggested over the CAM procedure if patients have a type B2 or C glenoid according to the Walch classification or less than 2 mm of glenohumeral joint space [8].
  • CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings, while hemiarthroplasty or total shoulder arthroplasty are feasible options for those with humeral head incongruity or large anterior osteophytes [12].
  • Arthroscopic treatment may be the best alternative when joint reconstruction is not desirable, possible, or practical [23].
  • Arthroscopic intervention may be more suitable for elderly patients with significant medical comorbidities who might be unable to tolerate the stresses of major surgery [23].
  • Arthroscopic treatment may be suitable for young patients with early onset arthritis who are not ideal candidates for total shoulder arthroplasty due to concerns related to prosthesis longevity or high functional demands [23].
  • Arthroscopic treatment may be indicated for patients with significant pain but only mild arthritic changes in the glenohumeral joint, making it difficult to justify arthroplasty [23].
  • Arthroscopy provides an opportunity to diagnose and treat coexistent soft tissue pathology in patients with osteoarthritis, which may eliminate the need for arthroplasty [23].
  • Arthroscopic treatment is an option when significant arthritis is noted intraoperatively that was not observed on preoperative workup [23].

Operative Technique

  • The CAM procedure involves placing patients in the beach-chair position and performing diagnostic arthroscopy to identify and treat all intra-articular pathologic abnormalities [5].
  • Degenerative labral tissue and unstable chondral injuries are debrided during the CAM procedure [5].
  • Loose bodies are removed during the CAM procedure when present [5].
  • Areas of synovitis are addressed with either a mechanical shaver or a radiofrequency device during the CAM procedure [5].
  • Microfracture is performed if a focal chondral defect is noted on either the glenoid or humeral head during the CAM procedure [5].
  • An accessory posteroinferior portal is established under spinal-needle localization during the CAM procedure [5].
  • Inferior humeral head osteophytes are resected with a high-speed bur through the accessory posteroinferior portal during the CAM procedure [5].
  • Curettes are used to remove bone from areas that are difficult to reach with motorized instruments, such as the anteroinferior quadrant, during the CAM procedure [5].
  • Inferior capsular release is performed during the CAM procedure [5].
  • The axillary nerve is identified just inferior to the joint, where it passes from anteromedial to posterolateral toward the quadrilateral space, if preoperative symptoms and imaging suggest axillary nerve compression [5].
  • The axillary nerve is carefully decompressed from proximal to distal, taking care to identify and preserve all arborizing branches [5].
  • Axillary nerve decompression is considered if an inferior humeral osteophyte changed the course of the nerve as determined on preoperative MRI, if observed intraoperatively by displacement of the inferior capsule, or if preoperative symptoms consistent with axillary nerve impingement or compression were present [5].
  • The CAM procedure builds on previously described arthroscopic techniques for glenohumeral osteoarthritis, including debridement, chondroplasty, synovectomy, loose body removal, capsular release, and subacromial decompression [8].
  • The CAM procedure adds inferior humeral osteoplasty, a complete capsular release, axillary nerve neurolysis, long head of the biceps tenodesis, and microfracture to previously described techniques [8].
  • Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis [14].
  • It can be technically demanding to release an axillary nerve arthroscopically and potentially dangerous to perform this procedure in the hands of less experienced arthroscopists who could risk nerve injury or transection [4].
  • A certain skill level and proficiency with shoulder arthroscopy are required to undertake some of the components of CAM of primary glenohumeral osteoarthritis [4].

Outcomes and Survivorship

  • The CAM procedure demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction for glenohumeral osteoarthritis [6].
  • The survivorship rate after the arthroscopic CAM procedure for glenohumeral osteoarthritis is 76.9% at a minimum of 5 years postoperatively [6].
  • Arthroscopic treatment of glenohumeral osteoarthritis provides improvements in range of motion and patient-reported outcomes with minimal complications [13].
  • Arthroscopic debridement and biological resurfacing of the glenoid is a minimally invasive therapeutic option for pain relief, functional improvement, and patient satisfaction in glenohumeral osteoarthritis in the intermediate-term [24].
  • Treatment of glenohumeral arthritis with arthroscopic glenoid resurfacing provided superior results to previously performed arthroscopic procedures in a series of patients with failed previous arthroscopic debridement [9].
  • Arthroscopic debridement is an excellent treatment for elderly patients with modest functional demands, though long-term consequences require further evaluation [10].

Limitations and Evidence Quality

  • Debate remains regarding the durability of managing primary glenohumeral arthritis arthroscopically [4].
  • Some 2- and 5-year follow-up data for arthroscopic management of primary glenohumeral arthritis remain limited to level IV series [4].
  • Previously published literature places survivorship at 85% at 2 years postoperatively after arthroscopic management of primary glenohumeral arthritis [4].
  • Previously published literature places survivorship at 76.9% at 5 years after arthroscopic management of primary glenohumeral arthritis [4].
  • It is unclear whether the reported survivorship rates represent the natural history of primary glenohumeral arthritis or whether arthroscopic management delays arthritis progression because no control group exists for the previously published case series [4].
  • There may be a placebo effect for shoulder arthroscopy that may improve patient outcomes in the short- and mid-term after surgery [4].
  • Most studies on arthroscopic management of glenohumeral osteoarthritis are level IV with low patient numbers and relatively short follow-up [4].
  • The American Academy of Orthopaedic Surgeons clinical practice guidelines classify the use of arthroscopy for the treatment of glenohumeral arthritis as grade I, implying that they are unable to recommend for or against this option [23].
  • A systematic review of the literature showed that arthroscopic debridement for glenohumeral arthritis lacks high-quality evidence to support its routine use [23].
  • A systematic review shows that arthroscopic debridement for glenohumeral arthritis lacks high-quality evidence to support its routine use [16].
  • Although there are limited nonarthroplasty surgical options available for glenohumeral arthritis, isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients [15].

Axillary Nerve Injury Risk

  • Arthroscopic release of the axillary nerve is technically demanding and potentially dangerous for less experienced arthroscopists, who risk nerve injury or transection [4].
  • A certain skill level and proficiency with shoulder arthroscopy are required to undertake some components of the CAM procedure [4].

General Complication Profile

Recovery

  • The CAM procedure reduced pain, improved function, and provided reasonable short-term durability for young, active patients with advanced shoulder OA [2].
  • The comprehensive arthroscopic management procedure provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis by reducing pain and improving function [3].
  • Arthroscopic debridement improved clinical outcome in 68% of patients suffering from advanced OA of glenohumeral joint [7].
  • Arthroscopic debridement with capsular release may provide a window of improved symptoms and function before deterioration of the joint leads to a more significant operation, especially in younger patients with mild or moderate osteoarthritic changes [17].
  • The CAM procedure demonstrated significant improvements in midterm clinical outcomes and high patient satisfaction after the arthroscopic CAM procedure for GHOA [6].
  • The CAM procedure demonstrated a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
  • After the CAM procedure, an 84% survivorship was found at 3 years [25].
  • After the CAM procedure, a 72% survivorship was found at 5 years [25].
  • The majority of patients demonstrated sustained improvement in patient-reported outcomes and satisfaction without conversion to total shoulder arthroplasty at long-term follow-up [18].
  • Some patients progressed to arthroplasty after the CAM procedure [18].

Key Evidence

  • [L4] The authors recommend a systematic, inclusive approach to the array of pathologies encountered in the setting of early glenohumeral arthritis: the Comprehensive Arthroscopic Management (CAM) procedure. [1] (10.1016/j.arthro.2022.01.033)
  • [L4] The CAM procedure reduced pain, improved function, and provided reasonable short-term durability for young, active patients with advanced shoulder OA, serving as a joint-preserving alternative to arthroplasty. [2] (10.1016/j.arthro.2012.10.028)
  • [Paper] The comprehensive arthroscopic management procedure provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis by reducing pain and improving function. [3] (10.1016/j.eats.2015.04.003)
  • [L5] [4] (10.5435/jaaos-d-17-00214)
  • [L3] [5] (10.1177/0363546516668823)
  • [L4] This study demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction after the arthroscopic CAM procedure for GHOA, with a 76.9% survivorship rate at a minimum of 5 years postoperatively. [6] (10.1177/0363546516656372)
  • [L3] Arthroscopic debridement improved clinical outcome in 68% of patients suffering from advanced OA of glenohumeral joint. [7] (10.1186/s12891-015-0741-9)
  • [L3] [8] (10.1177/0363546520962756)
  • [L4] Treatment of glenohumeral arthritis with arthroscopic glenoid resurfacing provided superior results in this series to their previously performed arthroscopic procedure. [9] (10.1016/j.arthro.2009.04.015)
  • [L3] Arthroscopic debridement is an excellent treatment for elderly patients with modest functional demands, though long-term consequences require further evaluation. [10] (10.1007/s00402-004-0738-6)
  • [L4] CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings, while HA or TSA are feasible options for those with humeral head incongruity or large anterior osteophytes. [12] (10.1530/eor-2023-0156)
  • [L1] Arthroscopic treatment of glenohumeral osteoarthritis provides improvements in ROM and patient-reported outcomes with minimal complications. [13] (10.1016/j.arthro.2020.02.036)
  • [L4] Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis. [14] (10.1007/s00167-023-07377-0)
  • [L4] Although there are limited nonarthroplasty surgical options available for glenohumeral arthritis, isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients. [15] (10.1016/j.arthro.2014.08.025)
  • [L1] This systematic review shows that arthroscopic debridement for glenohumeral arthritis lacks high-quality evidence to support its routine use. [16] (10.1016/j.arthro.2013.02.022)
  • [L4] Arthroscopic debridement with capsular release may provide a window of improved symptoms and function before deterioration of the joint leads to a more significant operation, especially in younger patients with mild or moderate osteoarthritic changes. [17] (10.1016/j.arthro.2006.11.016)
  • [L4] The majority of patients demonstrated sustained improvement in patient-reported outcomes and satisfaction without conversion to total shoulder arthroplasty at long-term follow-up, although some patients progressed to arthroplasty. [18] (10.1177/2325967121s00213)
  • [L4] Surgical arthroscopic repair was possible in all cases of acute or recurrent instability with well-defined exclusion criteria. [19] (10.1055/s-0032-1327656)
  • [L4] Arthroscopic debridement and biological resurfacing of the glenoid is a minimally invasive therapeutic option for pain relief, functional improvement and patient satisfaction, in glenohumeral osteoarthritis, in the intermediate-term. [24] (10.1007/s00167-010-1155-8)
  • [L4] After the CAM procedure we found an 84% survivorship at 3 years and 72% survivorship at 5 years. [25] (10.1177/2325967116s00104)

References

[1] Comprehensive Arthroscopic Management of Shoulder Arthritis. Arthroscopy. 2022. DOI: 10.1016/j.arthro.2022.01.033

[2] Comprehensive Arthroscopic Management (CAM) Procedure: Clinical Results of a Joint‐Preserving Arthroscopic Treatment for Young, Active Patients With Advanced Shoulder Osteoarthritis. Arthroscopy. 2013. DOI: 10.1016/j.arthro.2012.10.028

[3] The Comprehensive Arthroscopic Management Procedure for Treatment of Glenohumeral Osteoarthritis. Arthroscopy Techniques. 2015. DOI: 10.1016/j.eats.2015.04.003

[4] Arthroscopic Management of Glenohumeral Arthritis: A Joint Preservation Approach. Journal of the American Academy of Orthopaedic Surgeons. 2018. DOI: 10.5435/jaaos-d-17-00214

[5] Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis: Preoperative Factors Predictive of Treatment Failure. The American Journal of Sports Medicine. 2016. DOI: 10.1177/0363546516668823

[6] Survivorship and Patient-Reported Outcomes After Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis. The American Journal of Sports Medicine. 2016. DOI: 10.1177/0363546516656372

[7] Relationship between probability of future shoulder arthroplasty and outcomes of arthroscopic debridement in patients with advanced osteoarthritis of glenohumeral joint. BMC Musculoskeletal Disorders. 2015. DOI: 10.1186/s12891-015-0741-9

[8] Survivorship and Patient-Reported Outcomes After Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis: Minimum 10-Year Follow-up. The American Journal of Sports Medicine. 2020. DOI: 10.1177/0363546520962756

[9] Arthroscopic Glenoid Resurfacing: Results in Patients With Failed Previous Arthroscopic Debridement (SS‐14). Arthroscopy. 2009. DOI: 10.1016/j.arthro.2009.04.015

[10] Arthroscopic debridement of massive rotator cuff tears: negative prognostic factors. Archives of Orthopaedic and Trauma Surgery. 2004. DOI: 10.1007/s00402-004-0738-6

[12] Comprehensive arthroscopic management versus total shoulder arthroplasty and hemiarthroplasty in patients with primary glenohumeral arthritis younger than 50 years old. EFORT Open Reviews. 2026. DOI: 10.1530/eor-2023-0156

[13] Outcomes and Survivorship After Arthroscopic Treatment of Glenohumeral Arthritis: A Systematic Review. Arthroscopy. 2020. DOI: 10.1016/j.arthro.2020.02.036

[14] Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2023. DOI: 10.1007/s00167-023-07377-0

[15] Arthroscopic Debridement and Capsular Release for the Treatment of Shoulder Osteoarthritis. Arthroscopy. 2014. DOI: 10.1016/j.arthro.2014.08.025

[16] What Is the Role of Arthroscopic Debridement for Glenohumeral Arthritis? A Critical Examination of the Literature. Arthroscopy. 2013. DOI: 10.1016/j.arthro.2013.02.022

[17] Arthroscopic Debridement and Capsular Release for Glenohumeral Osteoarthritis. Arthroscopy. 2007. DOI: 10.1016/j.arthro.2006.11.016

[18] Survivorship and Patient-Reported Outcomes After Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis: Minimum 10-Year Follow-up. Orthopaedic Journal of Sports Medicine. 2021. DOI: 10.1177/2325967121s00213

[19] Arthroscopic Treatment of Glenohumeral Instability in Soccer Goalkeepers. International Journal of Sports Medicine. 2012. DOI: 10.1055/s-0032-1327656

[22] Rockwood And Matsen S The Shoulder. Arthroscopic Management of Prearthritic and Arthritic Conditions of the Shoulder and the Postarthroplasty Shoulder > Radiographic Evaluation.

[23] Rockwood And Matsen S The Shoulder. Arthroscopic Management of Prearthritic and Arthritic Conditions of the Shoulder and the Postarthroplasty Shoulder > INDICATIONS FOR ARTHROSCOPIC TREATMENT.

[24] Arthroscopic debridement and biological resurfacing of the glenoid in glenohumeral arthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2010. DOI: 10.1007/s00167-010-1155-8

[25] Survivorship after Arthroscopic Management of Glenohumeral Osteoarthritis with a Minimum 5 year Follow-up. Orthopaedic Journal of Sports Medicine. 2016. DOI: 10.1177/2325967116s00104

[29] Rockwood And Matsen S The Shoulder. Shoulder and Elbow Specialty Clinic Workers’ Survey > ANATOMY.

[30] A Lange Medical Book Current Diagnosis Treatment In Orthopedics Fifth Edition. 2Musculoskeletal Trauma Surgery > SHOULDER AND ARM INJURIES.

[31] Rockwood And Green S Fractures In Adults. 29: Principles of Nonunion and Bone Defect Treatment > Applied Anatomy Related to Scapular Fractures.

[32] Aaos Comprehensive Orthopaedic Review 3. Anatomy of the Shoulder, Arm, and Elbow > I. Shoulder.

[33] Rockwood And Matsen S The Shoulder. Developmental Anatomy of the Shoulder and Anatomy of the Glenohumeral Joint > Bursae.

[35] Orthopaedic Knowledge Update Sports Medicine 6. Diagnostic Ultrasonography and Ultrasonography-­Guided Procedures > Annotated References.

[37] Apley And Solomon S Concise System Of Orthopaedics And Trauma. INVESTIGATION.

[39] Rockwood And Matsen S The Shoulder. Developmental Anatomy of the Shoulder and Anatomy of the Glenohumeral Joint > SENIOR EDITOR COMMENTARY.

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.